Filing Details
Protagenic Therapeutics, Inc.\new (NASDAQ:PTIX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedNASDAQ:PTIX
Protagenic Therapeutics, Inc.\new (PTIX) Files Annual Report with SEC
Protagenic Therapeutics, Inc.\new (NASDAQ:PTIX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Protagenic Therapeutics, Inc.\new (NASDAQ:PTIX) · 10k filed
- Form
- 10-K
At a glance
Key takeaways
- Protagenic Therapeutics, Inc. (NASDAQ: PTIX) filed its annual 10-K report for fiscal year 2026 on August 14, 2026, containing comprehensive financial statements and management analysis.
- The company's stock trades at $0.36 per share with a market capitalization of $3.0 million as of the filing date.
- The 10-K filing includes detailed risk factors, long-term debt schedules, and accounting changes that investors should review for material developments affecting the company's financial position.
Market Context
Protagenic Therapeutics, Inc.\new's stock currently trades at $0.36 with a market capitalization of $3.0M.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For Protagenic Therapeutics, Inc.\new investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for Protagenic Therapeutics, Inc.\new are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PTIX Stock Page
Frequently Asked Questions
Where can I read PTIX's SEC filings?
Browse all filings on our PTIX SEC filings page.
What types of SEC filings does Protagenic Therapeutics, Inc.\new file?
Public companies like Protagenic Therapeutics, Inc.\new file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.